Abstract:Endometriosis is an estrogen-dependent gynecologic disease, which is characterized by the elevated ratio of ERβ/ERα expression. Retrograde menstruation leads to ectopic erythrocytes deposition and iron overload at pelvic cavity in endometriosis. Lipocalin 2 (LCN2) is a secretory protein that plays important role during iron transport and metabolism. To date, the relationship of estrogen and iron homeostasis is not well studied yet. The aim of our study was to investigate the role of estrogen in regulating iron metabolism in endometriosis. Sixty-eight women with endometriosis and forty-three women without endometriosis (controls) were included, and their serum levels of estrodiol and LCN2 were determined for via ELISA. Primary cultures of ESCs were obtained in vitro. The expression of estrogen receptor (ER) α, ERβ, and LCN2 was examined by qPCR, western blot, and ELISA. ChIP was used to investigate how ER regulated LCN2. Cell viability was assessed by Cell Counting Kit-8 assay. Reactive oxygen species production was evaluated by dihydroethidium staining. In addition, the intracellular ferrous iron level (Fe2+ ) were examined using an iron assay kit. Ferroptosis was evaluated by Cyclooxygenase-2(COX-2), Acyl-CoA Synthetase Long Chain Family Member 4 (ACSL4), glutathione peroxidase 4 (GPX4) and ferritin heavy chain 1(FTH1). Elevated serum LCN2 levels were found in women with endometriosis compared to those without. A positive correlation of E2 and LCN2 was observed in endometriosis group but not in controls. E2 dose-dependently increased the LCN2 expression in ESCs. This was also seen in the presence of ERα antagonist alone but not with ERβ antagonist alone. Interestingly, ERα bind to LCN2 promoter and attenuated the expression of LCN2. Moreover, E2-induced LCN2 expression resulted increased intracellular iron concentrations. Importantly, LCN2 attenuated GPX4 and FTH1 expression, increased COX-2 and ACSL4 levels, which in turn inhibited the ferroptosis of ESCs. This ferroptosis inhibition effect can also be partly reversed by the inhibition of ERβ or overexpression of ERα. Our studies demonstrate that upregulated E2 may inhibit ferroptosis via ERβ/ERα/ LCN2 pathway, potentially resulted in endometriotic tissue survival and progression, ERβ/ERα/LCN pathway may be a potential target for endometriosis treatment.

Lipoxin A4 Regulates Expression of the Estrogen Receptor and Inhibits 17Β-Estradiol Induced P38 Mitogen-Activated Protein Kinase Phosphorylation in Human Endometriotic Stromal Cells

Lipoxin A(4) Suppresses the Development of Endometriosis in an Alx Receptor-Dependent Manner Via the P38 Mapk Pathway

Lipoxin A4 Suppresses Estrogen-Induced Epithelial-Mesenchymal Transition Via ALXR-Dependent Manner in Endometriosis

Effect of interleukin-1β and lipoxin A 4 in human endometriotic stromal cells: Proteomic analysis.

Lipoxin A4 Suppresses IL-1β-Induced Cyclooxygenase-2 Expression Through Inhibition of p38 MAPk Activation in Endometriosis

LncRNA MEG3-210 Regulates Endometrial Stromal Cells Migration, Invasion and Apoptosis Through P38 MAPK and PKA/SERCA2 Signalling Via Interaction with Galectin-1 in Endometriosis.

Autocrine Production of Interleukin-34 Promotes the Development of Endometriosis Through CSF1R/JAK3/STAT6 Signaling

Abstract #1504468: Estrogen Attenuates Ferroptosis Via Estrogen Receptor (ER) Β/erα/lipocalin 2 Pathway in Endometriosis

Lipoxin A4 blocks embryo implantation by controlling estrogen receptor a activity

The inhibitory effect of 15-R-LXA4 on experimental endometriosis.

Lipoxin A4 depresses inflammation and promotes autophagy via AhR/mTOR/AKT pathway to suppress endometriosis

15-Epi-lipoxin A4 inhibits the progression of endometriosis in a murine model

Reduced Alternative Splicing of Estrogen Receptor Alpha in the Endometrium of Women with Endometriosis.

Estrogen Regulates the Expression and Function of Lncrna-H19 in Ectopic Endometrium

C-Jun Nh2-Terminal Kinase and P38 Inhibition Suppresses Prostaglandin E2-Stimulated Aromatase and Estrogen Receptor Levels in Human Endometriosis

Lipoxin A4 Interferes with Embryo Implantation Via Suppression of Epithelial‐mesenchymal Transition

Preeclampsia is Associated with A Deficiency of Lipoxin A4, an Endogenous Anti-Inflammatory Mediator

Estrogen Restricts the Apoptosis of Endometrial Stromal Cells by Promoting TSLP Secretion.

The Lipid-related Effects of Resveratrol on Human Ectopic Endometrial Stromal Cells and a Rat Model of Endometriosis

Estetrol Inhibits Endometriosis Development in an In Vivo Murine Model

Lipoxin A 4 Suppresses Lipopolysaccharide-Induced Hela Cell Proliferation and Migration via NF-κB Pathway